HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Emivirine

HCID 65013
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
149950-60-7
Standard SMILES
CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)[nH]c1=O
InChIKey
MLILORUFDVLTSP-UHFFFAOYSA-N
Molecular formula
C17H22N2O3
Average molar mass
302.37 g/mol
Monoisotopic mass
302.16304257

Overview

Emivirine is a pyrimidone that is uracil which is substituted at positions 1, 5 and 6 by ethoxymethyl, isopropyl, and benzyl groups, respectively. A non-nucleoside inhibitor of HIV-1 reverse transcriptase, emivirine was an unsuccessful experimental agent for the treatment of HIV. It has a role as an antiviral drug and a HIV-1 reverse transcriptase inhibitor. It is functionally related to a uracil.

Names & identifiers

Preferred name
Emivirine
IUPAC
6-benzyl-1-(ethoxymethyl)-5-propan-2-ylpyrimidine-2,4-dione
English name
emivirine
Molecular formula
C17H22N2O3
Molecular weight
302.37

Names & synonyms

Emivirine149950-60-7CoactinonMKC-4426-Benzyl-1-(ethoxymethyl)-5-isopropyluracilEmivirina1-(Ethoxymethyl)-5-(1-methylethyl)-6-(phenylmethyl)-2,4(1H,3H)-pyrimidinedioneX87G8IX72O6-benzyl-1-(ethoxymethyl)-5-(1-methylethyl)uracil2,4(1H,3H)-Pyrimidinedione, 1-(ethoxymethyl)-5-(1-methylethyl)-6-(phenylmethyl)-CHEBI:44143DTXSID80164437
Show more names
MKC 442DRG0302DRG 0302DRG-0302Emivirine(MKC-442)Emivirine, 10 mM in DMSO1-(Ethoxymethyl)-6-benzyl-5-isopropyluracil
6-benzyl-1-(ethoxymethyl)-5-(propan-2-yl)pyrimidine-2,4(1H,3H)-dione1-(ethoxymethyl)-5-(1-methylethyl)-6-(phenylmethyl)pyrimidine-2,4(1H,3H)-dione6-benzyl-1-ethoxymethyl-5-isopropyluracilemivirinumRefChem:590754DTXCID50869286-benzyl-1-(ethoxymethyl)-5-isopropyl-uracilI-EBU

Database identifiers

CAS
149950-60-7

Properties

Computed structural properties

XLogP
2.6
Topological polar surface area
58.6 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
6
Heavy atoms
22
Formal charge
0
Complexity
451

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
LogP2.35

Physicochemical properties

Melting point
109.1 · 109.1-110.7 °C(Solv: ethanol (64-17-5); water (7732-18-5))
Density
1.133 · 1.133±0.06 g/cm3(Predicted)
storage temp.
-20 °C · Store at -20°C
pka
9.46 · 9.46±0.40(Predicted)
form
Solid
color
White to off-white
InChI
InChI=1S/C17H22N2O3/c1-4-22-11-19-14(10-13-8-6-5-7-9-13)15(12(2)3)16(20)18-17(19)21/h5-9,12H,4,10-11H2,1-3H3,(H,18,20,21)
InChIKey
MLILORUFDVLTSP-UHFFFAOYSA-N
SMILES
C1(=O)N(COCC)C(CC2=CC=CC=C2)=C(C(C)C)C(=O)N1
FDA UNII
87 G8IX72O · X87G8IX72O
Symbol(GHS)
7 · GHS07

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P280-P301+P312-P302+P352-P305+P351+P338

Chemistry & industry

Pharmacology

MeSH Pharmacological ClassificationInhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template.

Applications

UsesTreatment of HIV-1 infections (non-nucleoside reverse transcriptase inhibitor).

UsesEmivirine can be used to treat disease cause by SARS-CoV-2

Suppliers30 total

北京华美互利生物化工010-56205725 · [email protected]
沈阳中申泽康生物医学技术研究有限公司024-88590548 18698872706 · [email protected]
武汉敬康恩生物医药科技有限公司13720134139 086-15871494362 13720134139 · [email protected]
Nantong HI-FUTURE Biology Co., Ltd.+86-18051384581 · [email protected]
LGM Pharma1-(800)-881-8210 · [email protected]
欧利希(湖北)医药科技有限公司17316404525 17316404525 · [email protected]
銳迪國際科技有限公司18024082417 · [email protected]
北京博奥森生物技术有限公司400-901-9800 18611424007 · [email protected]
NANJING YINGWEN BIOTECHNOLOGY CO LTD+8613382787392 · [email protected]

Related reactions

2 records
New reaction record
HRID 1451210 reaction equation
HRID 1451210As productuspto-grants-1997_02
HRID 2153986 reaction equation
HRID 2153986As productTraining data from https://doi.org/10.1039/C8SC04228D (4/10)

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
PubChem CID
65013
DTXSID
DTXSID80164437
ChEMBL
CHEMBL35033
ChEBI
CHEBI:44143
UNII
X87G8IX72O
Nikkaji
J556.890K
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P280-P301+P312-P302+P352-P305+P351+P338
Shanghai Witofly Chemical Co.,Ltd
[email protected]
Wuhan Jingkang en Biomedical Technology Co., Ltd+86-0086-13720134139 · [email protected]
常州翔龙医药科技有限公司18915873328 18915873328 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
合肥孚亚生物技术有限公司18096409024 · [email protected]
Alfa Chemistry+1-5166625404 · [email protected]
上海阿拉丁生化科技股份有限公司6206333 13167063860 · [email protected]
上海一飞生物科技有限公司021-65675885 18964387627 · [email protected]
上海源叶生物科技有限公司18916372613 · [email protected]
武汉沃格达生物科技有限公司15071299552 · [email protected]
上海立崎生物医学研究中心18014399201 · [email protected]
南通全益生物科技有限公司+86-0513; 18051384581 · [email protected]
Shenyang Zhongshen Zekang Biomedical Technology Research Co., Ltd+86-18341751992 +86-15382112998 · [email protected]
ATK CHEMICAL COMPANY LIMITED+undefined-21-51877795 · [email protected]
Wuhan Topule Biopharmaceutical Co., Ltd+86-18327326525 · [email protected]
TargetMol中国(陶术生物)4008200310 15002144251 · [email protected]
上海传芊化工科技中心15869524721 · [email protected]
南京世洲生物科技有限公司025-85560043 13675144456 · [email protected]
郑州研德生物科技有限公司13298105281 · [email protected]
上海阿摩尔生物科技有限公司13370042665 18916960931 · [email protected]
Additional notes · 1 item

DefinitionChEBI: A pyrimidone that is uracil which is substituted at positions 1, 5 and 6 by ethoxymethyl, isopropyl, and benzyl groups, respectively. A non-nucleoside inhibitor of HIV-1 reverse transcriptase, emivirine was an unsuccessful experimental agent for the treatm nt of HIV.